These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 8040121)
21. Liposomal hamycin in the control of experimental aspergillosis in mice: effect of phosphatidic acid with and without cholesterol. Moonis M; Ahmad I; Bachhawat BK J Antimicrob Chemother; 1993 Apr; 31(4):569-79. PubMed ID: 8514651 [TBL] [Abstract][Full Text] [Related]
22. Liposomal amphotericin B activates antifungal resistance with reduced toxicity by diverting Toll-like receptor signalling from TLR-2 to TLR-4. Bellocchio S; Gaziano R; Bozza S; Rossi G; Montagnoli C; Perruccio K; Calvitti M; Pitzurra L; Romani L J Antimicrob Chemother; 2005 Feb; 55(2):214-22. PubMed ID: 15649994 [TBL] [Abstract][Full Text] [Related]
23. The role of macrophages in LPS-induced lethality and tissue injury. Groeneveld PH; Claassen E; Kuper CF; Van Rooijen N Immunology; 1988 Mar; 63(3):521-7. PubMed ID: 2965101 [TBL] [Abstract][Full Text] [Related]
24. [Remission of invasive sinusal and pulmonary aspergillosis with liposomal amphotericin B in a patient with chronic lymphatic leukemia following failure with conventional amphotericin]. Palacio C; Acebedo G; López A; Jodar JM Sangre (Barc); 1994 Oct; 39(5):389-92. PubMed ID: 7754445 [TBL] [Abstract][Full Text] [Related]
25. Liposomal amphotericin B for treatment of pulmonary aspergillosis in a heart transplant patient. Katz NM; Pierce PF; Anzeck RA; Visner MS; Canter HG; Foegh ML; Pearle DL; Tracy C; Rahman A J Heart Transplant; 1990; 9(1):14-7. PubMed ID: 2313415 [TBL] [Abstract][Full Text] [Related]
26. Preclinical & pharmaceutical testing of liposomal amphotericin B. Gokhale PC; Kotwani RN; Dange SY; Kshirsagar NA; Pandya SK Indian J Med Res; 1993 Apr; 98():75-8. PubMed ID: 8344735 [TBL] [Abstract][Full Text] [Related]
27. Tuftsin-bearing liposomes as drug vehicles in the treatment of experimental aspergillosis. Owais M; Ahmed I; Krishnakumar B; Jain RK; Bachhawat BK; Gupta CM FEBS Lett; 1993 Jul; 326(1-3):56-8. PubMed ID: 8325389 [TBL] [Abstract][Full Text] [Related]
28. Liposome-encapsulated dichloromethylene diphosphonate induces macrophage apoptosis in vivo and in vitro. Naito M; Nagai H; Kawano S; Umezu H; Zhu H; Moriyama H; Yamamoto T; Takatsuka H; Takei Y J Leukoc Biol; 1996 Sep; 60(3):337-44. PubMed ID: 8830790 [TBL] [Abstract][Full Text] [Related]
29. Nanosomal Amphotericin B is an efficacious alternative to Ambisome for fungal therapy. Sheikh S; Ali SM; Ahmad MU; Ahmad A; Mushtaq M; Paithankar M; Mandal J; Saptarishi D; Sehgal A; Maheshwari K; Ahmad I Int J Pharm; 2010 Sep; 397(1-2):103-8. PubMed ID: 20621173 [TBL] [Abstract][Full Text] [Related]
30. In vitro and in vivo elimination of macrophage tumor cells using liposome-encapsulated dichloromethylene diphosphonate. van Rooijen N; Kors N; ter Hart H; Claassen E Virchows Arch B Cell Pathol Incl Mol Pathol; 1988; 54(4):241-5. PubMed ID: 2895535 [TBL] [Abstract][Full Text] [Related]
31. Mannosylated liposomes as carriers for hamycin in the treatment of experimental aspergillosis in Balb/C mice. Moonis M; Ahmad I; Bachhawat BK J Drug Target; 1993; 1(2):147-55. PubMed ID: 8069553 [TBL] [Abstract][Full Text] [Related]
32. Altered tissue distribution of amphotericin B by liposomal encapsulation: comparison of normal mice to mice infected with Candida albicans. Lopez-Berestein G; Rosenblum MG; Mehta R Cancer Drug Deliv; 1984; 1(3):199-205. PubMed ID: 6399857 [TBL] [Abstract][Full Text] [Related]
33. Incorporation of amphotericin B in tuftsin-bearing liposomes showed enhanced efficacy against systemic cryptococcosis in leucopenic mice. Khan MA; Nasti TH; Owais M J Antimicrob Chemother; 2005 Oct; 56(4):726-31. PubMed ID: 16126780 [TBL] [Abstract][Full Text] [Related]
34. Distribution of amphotericin B-arabinogalactan conjugate in mouse tissue and its therapeutic efficacy against murine aspergillosis. Falk R; Grunwald J; Hoffman A; Domb AJ; Polacheck I Antimicrob Agents Chemother; 2004 Sep; 48(9):3606-9. PubMed ID: 15328139 [TBL] [Abstract][Full Text] [Related]
35. Comparative study on the efficacy of AmBisome and Fungizone in a mouse model of pulmonary aspergillosis. Takemoto K; Yamamoto Y; Ueda Y; Sumita Y; Yoshida K; Niki Y J Antimicrob Chemother; 2006 Apr; 57(4):724-31. PubMed ID: 16446374 [TBL] [Abstract][Full Text] [Related]
36. Efficacy of unilamellar liposomal amphotericin B in treatment of pulmonary aspergillosis in persistently granulocytopenic rabbits: the potential role of bronchoalveolar D-mannitol and serum galactomannan as markers of infection. Francis P; Lee JW; Hoffman A; Peter J; Francesconi A; Bacher J; Shelhamer J; Pizzo PA; Walsh TJ J Infect Dis; 1994 Feb; 169(2):356-68. PubMed ID: 8106769 [TBL] [Abstract][Full Text] [Related]
38. Growth inhibition of macrophage-like and other cell types by liposome-encapsulated, calcium-bound, and free bisphosphonates in vitro. Mönkkönen J; Taskinen M; Auriola SO; Urtti A J Drug Target; 1994; 2(4):299-308. PubMed ID: 7858955 [TBL] [Abstract][Full Text] [Related]
39. Depletion of alveolar macrophages by liposome-encapsulated dichloromethylene diphosphonate. Berg JT; Lee ST; Thepen T; Lee CY; Tsan MF J Appl Physiol (1985); 1993 Jun; 74(6):2812-9. PubMed ID: 8365985 [TBL] [Abstract][Full Text] [Related]
40. In-vitro effects of liposome-encapsulated amphotericin B (AmBisome) and amphotericin B-deoxycholate (Fungizone) on the phagocytic and candidacidal function of human polymorphonuclear leucocytes. Pallister CJ; Johnson EM; Warnock DW; Elliot PJ; Reeves DF J Antimicrob Chemother; 1992 Sep; 30(3):313-20. PubMed ID: 1452496 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]